No quarterly revenue total was found in ODYSSEY HEALTH, INC.'s SEC filings.
Odyssey Health, Inc. (ODYY) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus.
Revenue
—
Net income
$-2.41M
-856.9% vs year-ago quarter
Operating cash flow
$-159,580
-231.1% vs year-ago quarter
Free cash flow
—
EPS
$-0.02
-799.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
110.22M
+10.4% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ODYY (OTC)
- Fiscal year ends
- July 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1626644
- Former names
- Odyssey Group International, Inc. (until Feb 18, 2022)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q4 FY2026 Jul 31, 2026 |
Q3 FY2026 Apr 30, 2026 |
Q2 FY2026 Jan 31, 2026 |
Q1 FY2026 Oct 31, 2025 |
Q4 FY2025 Jul 31, 2025 |
|---|---|---|---|---|---|
| Operating income | -$130,307 | -$297,554 | -$181,942 | -$303,190 | -$155,678 |
| Net income | -$2.4M | $765,890 | -$3.6M | -$483,447 | -$251,916 |
| Diluted EPS | -$0.02 | $0.01 | -$0.03 | $0.00 | -$0.00 |
| Operating cash flow | -$159,580 | -$318,521 | -$284,259 | -$283,998 | -$48,199 |
| Total assets | $147,859 | $373,779 | $721,304 | $143,622 | $49,723 |
| Stockholders' equity | -$12.1M | -$9.7M | -$10.6M | -$7.2M | -$7.0M |
| Cash and investments | $122,361 | $297,806 | $616,327 | $25,586 | $19,084 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 28, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 5, 2026 | Sep 29, 2026 |
| 10-Q | Quarterly report | Jun 12, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 26, 2026 | Sep 18, 2025 |
| 8-K |
Current report
Material agreement
|
May 11, 2026 | May 6, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 24, 2026 | Apr 21, 2026 |
All 275 Odyssey Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.